JP Morgan Maintains Overweight on Allient, Raises Price Target to $120
JP Morgan analyst Tomohiko Sano maintains Allient (NASDAQ:ALNT) with a Overweight and raises the price target from $95 to $120.
Read original at benzingaStocks · News reference
Allient Q2 Adj. EPS $0.80 Beats $0.61 Estimate, Sales $153.770M Beat $145.685M Estimate
Allient (NASDAQ:ALNT) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.61 by 31.15 percent. This is a 40.35 percent increase over earnings of $0.57 per share from the same
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 5, 2026, 8:13 PM
- Checked
- Aug 5, 2026, 8:13 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
JP Morgan Maintains Overweight on Allient, Raises Price Target to $95
JP Morgan analyst Tomohiko Sano maintains Allient (NASDAQ:ALNT) with a Overweight and raises the price target from $80 to $95.
Read original at benzinga